279 related articles for article (PubMed ID: 21556807)
21. [USE OF STATINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE TO PREVENT CARDIOVASCULAR DISEASE].
Zavidić T; Lodeta B; Lovrinić Đ
Acta Med Croatica; 2016 Dec; 70(4-5):301-7. PubMed ID: 29087163
[TBL] [Abstract][Full Text] [Related]
22. [Statins and kidney disease].
Bigazzi R; Grimaldi D; Bianchi S
G Ital Nefrol; 2012; 29(2):160-73. PubMed ID: 22538946
[TBL] [Abstract][Full Text] [Related]
23. Effects of statins on renal function.
Agarwal R
Mayo Clin Proc; 2007 Nov; 82(11):1381-90. PubMed ID: 17976359
[TBL] [Abstract][Full Text] [Related]
24. Statins in chronic kidney disease and kidney transplantation.
Kassimatis TI; Goldsmith DJ
Pharmacol Res; 2014 Oct; 88():62-73. PubMed ID: 24995940
[TBL] [Abstract][Full Text] [Related]
25. The lipid story in chronic kidney disease: a long story with a happy end?
Kujawa-Szewieczek A; Więcek A; Piecha G
Int Urol Nephrol; 2013 Oct; 45(5):1273-87. PubMed ID: 23054316
[TBL] [Abstract][Full Text] [Related]
26. [Chronic kidney disease and statins].
Matovinović MS
Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
[TBL] [Abstract][Full Text] [Related]
27. Statins in patients with chronic kidney disease: why, who and when?
Gluba A; Rysz J; Banach M
Expert Opin Pharmacother; 2010 Nov; 11(16):2665-74. PubMed ID: 20977401
[TBL] [Abstract][Full Text] [Related]
28. LDL-cholesterol lowering and renal outcomes.
Waters DD
Curr Opin Lipidol; 2015 Jun; 26(3):195-9. PubMed ID: 25887677
[TBL] [Abstract][Full Text] [Related]
29. Statins and renal disease: friend or foe?
Deshmukh A; Mehta JL
Curr Atheroscler Rep; 2011 Feb; 13(1):57-63. PubMed ID: 21053107
[TBL] [Abstract][Full Text] [Related]
30. [Statins in chronic renal disease].
Ferreira SR; Rocha AM; Saraiva JF
Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():45-9. PubMed ID: 16400399
[TBL] [Abstract][Full Text] [Related]
31. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
[TBL] [Abstract][Full Text] [Related]
32. HMG-CoA reductase inhibitors and the kidney.
Campese VM; Hadaya B; Chiu J
Curr Hypertens Rep; 2005 Oct; 7(5):337-42. PubMed ID: 16157074
[TBL] [Abstract][Full Text] [Related]
33. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials.
Chan DT; Irish AB; Dogra GK; Watts GF
Atherosclerosis; 2008 Feb; 196(2):823-34. PubMed ID: 17343861
[TBL] [Abstract][Full Text] [Related]
34. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
[TBL] [Abstract][Full Text] [Related]
35. Impact of Chronic Kidney Disease on Risk for Vascular Events.
Fan J; Salameh H
Curr Vasc Pharmacol; 2016; 14(5):409-414. PubMed ID: 27456102
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of statins in chronic kidney disease.
Sheng X; Murphy MJ; Macdonald TM; Wei L
QJM; 2012 Jul; 105(7):641-8. PubMed ID: 22383690
[TBL] [Abstract][Full Text] [Related]
37. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
[TBL] [Abstract][Full Text] [Related]
38. Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era.
Heymann EP; Kassimatis TI; Goldsmith DJ
J Nephrol; 2012; 25(4):460-72. PubMed ID: 22641572
[TBL] [Abstract][Full Text] [Related]
39. [Ezetimibe as a treatment for dyslipidaemia in CKD].
Żebrowski P; Kaszyńska M
Wiad Lek; 2019; 72(11 cz 2):2210-2213. PubMed ID: 31860838
[TBL] [Abstract][Full Text] [Related]
40. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.
Vaziri ND; Norris KC
Blood Purif; 2013; 35(1-3):31-6. PubMed ID: 23343544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
